Spring til hovednavigation
Spring til søgning
Spring til hovedindhold
Sorter
Keyphrases
Multiple Sclerosis
100%
Multiple Sclerosis Treatment
23%
Cerebrospinal Fluid
22%
Relapsing-remitting multiple Sclerosis
21%
Progressive multiple Sclerosis
17%
Natalizumab
14%
Disease Activity
12%
Optic Neuritis
11%
Interferon-beta (IFN-β)
9%
B Cells
9%
T Cells
8%
Neurofilament Light (NF-L)
8%
Myelin Basic Protein
7%
Interferon-α (IFN-α)
7%
Disease-modifying Therapy
7%
Healthy Controls
6%
Expanded Disability Status Scale
6%
Denmark
5%
National Cohort Study
5%
Oligoclonal Bands
5%
Central Nervous System
5%
Immunology and Microbiology
Multiple Sclerosis
75%
Cerebrospinal Fluid
21%
T Cell
11%
Natalizumab
11%
B Cell
10%
Relapsing Remitting Multiple Sclerosis
9%
Myelin
7%
Optic Neuritis
7%
Beta Interferon
7%
Inflammation
6%
Magnetic Resonance Imaging
5%
Central Nervous System
5%
Oligoclonal Band
5%
Methylprednisolone
5%
Neuroscience
Multiple Sclerosis
62%
Relapsing Remitting Multiple Sclerosis
10%
Biological Marker
9%
Optic Neuritis
8%
Magnetic Resonance Imaging
8%
Intrathecal
8%
T Cell
8%
Natalizumab
7%
